0000919574-20-002265.txt : 20200310 0000919574-20-002265.hdr.sgml : 20200310 20200310171039 ACCESSION NUMBER: 0000919574-20-002265 CONFORMED SUBMISSION TYPE: 13F-HR/A PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20191231 FILED AS OF DATE: 20200310 DATE AS OF CHANGE: 20200310 EFFECTIVENESS DATE: 20200310 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Kite Lake Capital Management (UK) LLP CENTRAL INDEX KEY: 0001687444 IRS NUMBER: 000000000 STATE OF INCORPORATION: X0 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR/A SEC ACT: 1934 Act SEC FILE NUMBER: 028-18700 FILM NUMBER: 20702874 BUSINESS ADDRESS: STREET 1: 1 KNIGHTSBRIDGE GREEN STREET 2: 6TH FLOOR CITY: LONDON STATE: X0 ZIP: SW1X 7QA BUSINESS PHONE: 44 20 7052 8311 MAIL ADDRESS: STREET 1: 1 KNIGHTSBRIDGE GREEN STREET 2: 6TH FLOOR CITY: LONDON STATE: X0 ZIP: SW1X 7QA 13F-HR/A 1 primary_doc.xml 13F-HR/A LIVE false true false 0001687444 XXXXXXXX 12-31-2019 12-31-2019 true 1 RESTATEMENT false Kite Lake Capital Management (UK) LLP
1 Knightsbridge Green 6th Floor London X0 SW1X 7QA
13F HOLDINGS REPORT 028-18700 Y This filing seeks to correct the Form 13F filed on February 14, 2020, by removing two lines of information under the issuer "SPDR S&P 500 ETF TR" as the positions listed were not held by the institutional investment manager as of December 31, 2019.
Rupert Haworth-Booth Chief Operating Officer 44-20-7052-8311 /s/ Rupert Haworth-Booth London X0 03-10-2020 1 5 31565 1 0001734681 028-18701 KL Special Opportunities Master Fund Ltd.
INFORMATION TABLE 2 infotable.xml BRISTOL MYERS SQUIBB CO RIGHT 99/99/9999 110122157 1331 442340 SH DFND 442340 0 0 CHINA BIOLOGIC PRODS HLDGS I COM G21515104 15309 131540 SH DFND 131540 0 0 CHINA BIOLOGIC PRODS HLDGS I COM G21515104 8826 75842 SH SOLE 75842 0 0 QIAGEN NV SHS NEW N72482123 3912 115753 SH DFND 115753 0 0 QIAGEN NV SHS NEW N72482123 2187 64702 SH SOLE 64702 0 0